Takeda Pharmaceutical Co., Ltd. (TAK)
16.40
+0.04
(+0.28%)
USD |
NYSE |
Apr 28, 16:00
16.60
+0.20
(+1.19%)
After-Hours: 20:00
Takeda Pharmaceutical EPS Diluted (Quarterly) : 0.2099 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sanofi | -- |
| Eli Lilly & Co. | 7.024 |
| Protagonist Therapeutics, Inc. | -0.6932 |
| Denali Therapeutics, Inc. | -0.7326 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 673.28M |
| Revenue (Quarterly) | 7.735B |
| Total Expenses (Quarterly) | 7.062B |
| Enterprise Value | 78.46B |
| Gross Profit Margin (Quarterly) | 54.43% |
| Profit Margin (Quarterly) | 8.70% |
| Earnings Yield | 1.47% |
| Operating Earnings Yield | 6.76% |
| Normalized Earnings Yield | 2.124 |